Document Detail


Radiotherapy in the treatment of advanced and recurrent prostate cancer.
MedLine Citation:
PMID:  23150090     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The incidence of advanced prostate cancer has decreased since the introduction of prostate-specific antigen (PSA) measurements. The treatment of these patients remains a challenge due to the bad prognosis and continues to be controversially discussed. The article discusses the questions concerning radiotherapy including pelvic lymph nodes as well as an additional androgen deprivation therapy. The risk of recurrent cancer has increased since the introduction of radical prostatectomy for patients with high risk factors or locally advanced tumors. In these cases adjuvant and salvage radiotherapy represent a mainstay of therapy. Low-dose rate (LDR) and high-dose rate (HDR) brachytherapy are primary treatment options for patients with low and high risk factors and localized disease. An elaborate management of treatment-related toxicities is mandatory and may provide persistent symptom relief. A comprehensive assessment of radiation side effects and treatment concepts is provided. The development of secondary cancers after radiotherapy represents a most severe side effect for which an assessment of available data is presented.
Authors:
D Böhmer
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-14
Journal Detail:
Title:  Der Urologe. Ausg. A     Volume:  -     ISSN:  1433-0563     ISO Abbreviation:  Urologe A     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1304110     Medline TA:  Urologe A     Country:  -    
Other Details:
Languages:  GER     Pagination:  -     Citation Subset:  -    
Affiliation:
Klinik für Radioonkologie, Charité Campus Virchow, Augustenburger Platz 1, 13353, Berlin, Deutschland, Dirk.Boehmer@charite.de.
Vernacular Title:
Strahlentherapie des fortgeschrittenen und rezidivierenden Prostatakarzinoms.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intermediate and high risk prostate cancer patients : Clinical significance of extended lymphadenect...
Next Document:  Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production...